Serum Pregenomic RNA Combined With Hepatitis B Core-Related Antigen Helps Predict the Risk of Virological Relapse After Discontinuation of Nucleos(t)ide Analogs in Patients With Chronic Hepatitis B

BACKGROUND AND AIM: Cessation of nucleos(t)ide analogs (NAs) therapy in patients with chronic hepatitis B (CHB) is uncommon. Although criteria for discontinuation appear in some guidelines, the indicators for assessing discontinuation of NAs are limited, whether NAs can be safely ceased remains a di...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fa-Da, Zhou, Jing, Li, Lan-Qing, Wang, Meng-Lan, Tao, Ya-Cao, Wang, Yong-Hong, Zhang, Dong-Mei, Chen, En-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257105/
https://www.ncbi.nlm.nih.gov/pubmed/35814664
http://dx.doi.org/10.3389/fmicb.2022.901233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257105/
https://www.ncbi.nlm.nih.gov/pubmed/35814664
http://dx.doi.org/10.3389/fmicb.2022.901233

Ejemplares similares